|
Prof. Salvatore DiMauro, M.D., was born in Verona, Italy, November 14, 1939, graduated in medicine from the University of Padua in 1963 and completed his residency in neurology in 1966. He then completed a postdoctoral fellowship in the Department of Neurology at the University of Pennsylvania. His research focuses on genetic errors of energy metabolism and he defines disease entities using both biochemical and molecular approaches. As an "enzyme defect hunter", DiMauro has documented the molecular basis of many enzyme deficiencies, including carnitine palmitoyltransferase deficiency, the first error of fatty acid oxidation to be recognized in humans. With colleagues at the University of Pennsylvania in the 1970s, DiMauro studied the second patient ever with Luft's disease, the prototypical (though also the rarest) mitochondrial disease.〔(Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. )〕 He is a Professor of Neurology at Columbia University, director of the H. Houston Merritt Clinical Research Center for Muscular Dystrophy 〔(The Merritt Center )〕 and Associate Chair of Related Diseases for Laboratory Research and Training.〔(The Neurological Institute of New York, Columbia University )〕 He is a trustee on the United Mitochondrial Disease Foundation.〔(UMDF )〕 Prof. DiMauro has scores of publications. He also has several books to his credit. His last book is titled Mitochondrial Medicine and was published in 2006.〔(Mitochondrial Medicine by Salvatore DiMauro, Eric A. Schon, Michio Hirano )〕 ==Early life and education== 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Salvatore DiMauro」の詳細全文を読む スポンサード リンク
|